DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,254 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $930,000 | -62.8% | 9,019 | -60.8% | 0.22% | -49.3% |
| Q3 2018 | $2,502,000 | +6.5% | 23,027 | -3.3% | 0.44% | -11.1% |
| Q2 2018 | $2,350,000 | +32.3% | 23,822 | +31.4% | 0.50% | +34.7% |
| Q1 2018 | $1,776,000 | +17.9% | 18,129 | +11.8% | 0.37% | -9.3% |
| Q4 2017 | $1,507,000 | -5.6% | 16,219 | -12.9% | 0.41% | -16.4% |
| Q3 2017 | $1,597,000 | +12.9% | 18,614 | +11.0% | 0.49% | +9.4% |
| Q2 2017 | $1,415,000 | -3.4% | 16,775 | -2.1% | 0.44% | -5.3% |
| Q1 2017 | $1,465,000 | -26.0% | 17,130 | -32.7% | 0.47% | -36.9% |
| Q4 2016 | $1,980,000 | +43.3% | 25,438 | +44.3% | 0.74% | +32.8% |
| Q3 2016 | $1,382,000 | -22.4% | 17,623 | 0.0% | 0.56% | -32.8% |
| Q2 2016 | $1,780,000 | +3.6% | 17,623 | -2.7% | 0.84% | -0.2% |
| Q1 2016 | $1,718,000 | +0.5% | 18,103 | -1.6% | 0.84% | +0.6% |
| Q4 2015 | $1,709,000 | +4.8% | 18,396 | -3.8% | 0.83% | -17.0% |
| Q3 2015 | $1,630,000 | +0.6% | 19,131 | +1.1% | 1.00% | -4.5% |
| Q2 2015 | $1,621,000 | -5.1% | 18,931 | -6.0% | 1.05% | -4.8% |
| Q1 2015 | $1,709,000 | -1.0% | 20,133 | 0.0% | 1.10% | -8.8% |
| Q4 2014 | $1,726,000 | +12.8% | 20,133 | 0.0% | 1.21% | +10.2% |
| Q3 2014 | $1,530,000 | – | 20,133 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |